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Abstract 
Nucleophosmin (NPM1) is an abundant and ubiquitously expressed phosphoprotein that is 
known to influence solid tumors progression. However, little is known about the role of 
NPM1 in leukemia. Here, we knocked down the NPM1 expression by RNA interference to 
investigate the role of NPM1 in leukemic cells proliferation and apoptosis. The interference 
vector pNPM1-shRNA was constructed and transfected into the human leukemic K562 cell 
line. The expression levels of NPM1 mRNA and protein were detected by quantitative re-
al-time PCR and Western blot, respectively. Cells proliferation potential in vitro was assessed 
by methyl thiazolyl tetrazolium (MTT) and colony formation assays. Flow cytometry was used 
to detect the distribution of cell cycle. Cellular apoptosis was reflected by the relative activ-
ities of caspase-3 and caspase-8. The results showed that the expression levels of NPM1 
mRNA and protein in K562 cells were significantly reduced after pNPM1-shRNA transfection. 
The cells growth was significantly inhibited in a time-dependent manner and the number of 
colonies was significantly reduced in the pNPM1-shRNA transfected cells. Meanwhile, the 
percentage of cells in G1 phase in the K562/pNPM1-shRNA cells was significantly increased. In 
addition, there were higher relative activities of caspase-3/8 in the pNPM1-shRNA transfected 
cells. These results indicate that down-regulation of NPM1 expression inhibits leukemic cells 
proliferation, blocks cell cycle progression and induces cellular apoptosis. It may implicate a 
potential target for leukemia gene therapy. 
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1. Introduction 
Nucleophosmin  (NPM1),  also  known  as  B23, 
encoded  by  the  NPM1  gene  maps  to  chromosome 
band 5q35 in humans [1]. NPM1 is an abundant and 
ubiquitously  expressed  phosphoprotein  that  plays 
important  roles  in  regulation  of  multiple  cellular 
functions, such as ribosome biogenesis and transport 
[2], centrosome duplication [3] and stress responses 
[4]. In addition, NPM1 is also essential for embryonic 
development;  and  it’s  inactivation  in  the  germ  line 
leads  to  a  series  of  developmental  defects  and  em-
bryonic  lethality  at  mid-gestation  [5,  6].  In  recent 
years, much of interest is paid on NPM1 because this Int. J. Med. Sci. 2011, 8 
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gene  implicated  in  human  tumorigenesis.  NPM1  is 
frequently  overexpression  in  solid  tumors  and  has 
been proposed as a marker for ovarian [7], colon [8], 
gastric [9], prostate [10] and thyroid tumor [11]. The 
overexpression  of  NPM1  also  has  been  detected  in 
leukemia  blast  and  cell  lines  [12,  13].  In  addition, 
NPM1 is frequently involved in chromosomal trans-
location  in  hematological  malignancies,  forming  fu-
sion proteins (NPM1-ALK [14], NPM1-RARa [15] and 
NPM1-MLF1 [16]). So, the change involved in NPM1 
plays an important role in leukemiagenesis.   
Accumulating evidences suggest NPM1 protein 
is one of the key elements in the regulation of nucle-
olar function. It involves in regulating the susceptibil-
ity of leukemia cells to chemotherapeutics or induc-
tion  of  cellular  apoptosis.  Overexpression  of  NPM1 
was  found  to  decrease  the  susceptibility  of  human 
HL-60  leukemic  cells  to  retinoic  acid  (RA)-induced 
apoptosis  [17],  and  to  lead  to  resistance  to  RA-  or 
TPA-induced  differentiation  [18],  while  the 
down-regulation of NPM1 made the cells more sus-
ceptible to BuONa-induced apoptosis [19]. Moreover, 
NPM1 also plays an important role in cellular mor-
talization  via  regulating  the  activity  of  telomerase 
[20]. Recently, some studies indicated that the muta-
tion  NPM1  aberrant  in  the  cytoplasm  of  leukemia 
blasts would interfere with wild-type NPM1 functions 
by binding and recruiting them into cytoplasm which 
may contribute to its leukemiagenesis [21]. In conclu-
sion, the complex behavior of the NPM1 protein de-
mands further studies to better determine the molec-
ular mechanisms and biological consequences  of its 
altered expression in leukemia. 
To elucidate the potential role of NPM1 in leu-
kemia, we used RNA interference to knock down the 
expression  of  NPM1  in  human  leukemic  K562  cells 
and  detected  the  effect  of  NPM1  gene  silencing  on 
cells proliferation, cell cycle distribution and cellular 
apoptosis. 
 
2. Materials and Methods 
2.1 Cell line and culture conditions 
Human myelogenous leukemic K562 cells (pur-
chased  from  the  Shanghai  Institutes  for  Biological 
Sciences) were routinely cultured in RPMI 1640 me-
dium (Gibco, MD, USA) supplemented with 10% fetal 
bovine  serum  (FBS,  Gibco,  MD,  USA)  in  a  5% 
CO2-humidified incubator at 37 °C. 
2.2 Construction interference vector 
For knock-down of NPM1 genes by RNA inter-
ference, the following RNA oligos specific for NPM1 
coding  region  were  used:  5’-AATGTCTGTACAG 
CCAACG-3’  [22].  The  oligonucleotides  for  shRNAs 
were then designed and the structure contained (5’ to 
3’) a BamHI site, the sense sequence (italicized), a loop 
region, the antisense sequence (italicized), a termina-
tion  sequence,  a  ScaI  restriction  site  and  a  HindⅢ 
cloning  site  (shNPM1  sense:  5’-GATCCAATGTCTG 
TACAGCCAACGTTCAAGACGCGTTGGCTGTACAG
ACATTTTTTTGTCGAC-3’;  antisense:  5’-AGCTTG 
TCGACAAAAAAATGTCTGTACAGCCAACGCGTCT
TGAACGTTGGCTGTACAGACATTG-3’).  Oligonu-
cleotides were annealed in 10 mM Tris and 20 mM 
NaCl (pH 7.6) by heating to 94 °C for 3 min followed 
by  slowly  cooling  to  room  temperature.  Dou-
ble-stranded oligonucleotides were then inserted into 
the  plasmid  vector  pGenesil-1  (Wuhan  Genesil  Bio-
technology Co., Ltd., Wuhan, China) via BamHI and 
Hind  Ⅲ  restriction  sites.  As  a  negative  control,  a 
scrambled sequence of shRNA was constructed by the 
same  strategy.  The  resulting  shRNA  expression 
plasmids  were  named  pNPM1-shRNA  and 
pshRNA-NC, respectively. Both of them can express 
enhanced green fluorescent protein (GFP). All clones 
were verified by DNA sequencing. 
2.3 Transient transfection 
The  K562  cells  (8.0×105/ml)  in  logarithmic 
growth phase were seeded in 6-well plate and trans-
fected with Lipofectamin 2000/pNPM1-shRNA com-
plexes  which  combined  at  a  1:  2.5  ratio.  The  com-
plexes  were  incubated  at  room  temperature  for  20 
min, and then added directly to the cells covered in a 
basic medium. After incubation at 37 °C for 6 h, the 
complexes  were  replaced  by  RPMI  1640  containing 
10%  FBS.  The  transfected  cells  were  named  as 
K562/pNPM1-shRNA.  The  control  cells, 
K562/pshRNA-NC and K562-mock, were established 
similarly.  Each  transfection  was  performed  in  inde-
pendent cultures and at different times. When tran-
sient  transfection  was  performed  for  48  h,  the  suc-
cessfully transfected cells with GFP protein were ver-
ified  by  fluorescent  microscopy.  Cells  transfection 
efficiency  is  reflected  by  the  percentage  of 
GFP-positive cells. 
2.4 Quantitative real-time PCR analysis 
Total  RNA  was  extracted  from  cells  in  each 
group, and the quantitative real-time PCR (qRT-PCR) 
was performed using a SYBR Green reaction (TaKaRa, 
Tokyo, Japan) kit and a Rotor-Gene 6000 Real-Time 
PCR machine (Corbett Research, Sydney, Australia). 
The expression levels of NPM1 were analyzed relative 
to the levels of the β-actin gene transcript. Sequences 
of the primers were as follows: NPM1: forward pri-
mers,  5’-ACTCCACCCTTTGCTTGGTTT-3’  and  re-Int. J. Med. Sci. 2011, 8 
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verse  primers,  5’-TTTGTCTCCCCACCATTTCC-3’; 
β-actin:  forward  primers,  5’-AGCGAGCAT 
CCCCCAAAGTT-3’  and  reverse  primers 
5’-GGGCACGAAGGCTCATCATT-3’.  The  reaction 
mixture for each direct qRT-PCR was performed us-
ing 10μl of SYBR Premix Ex Taw, 1 μl (0.4 μM) of each 
primer and 2 μl DNA, and in a total reaction volume 
of  20  μl.  qRT-PCR  reaction  condition  included  pre-
denaturation at 95 °C for 30 sec, followed by 40 cycles 
of denaturation at 95 °C for 5 sec and annealing at 60 
°C for 30 sec. Three independent experiments  were 
performed on the cells in independent cultures at 3 
different times. 
2.5 Western blot 
Cells in each group were washed with ice-cold 
phosphate-buffered saline (PBS) triplicate and lysed 
by lysis buffer supplemented with protease inhibitor 
cocktail. Protein concentrations were determined by 
BCA method. A total of 50 μg of protein was resolved 
in  12%  sodium  dodecyl  sulfate-polyacrylamide  gel, 
and  then  transferred  to  polyvinylidene  difluoride 
membrane. The member was blocked in 5% low-fat 
dry milk for 3 h, then was incubated with primary 
antibody for overnight at 4 °C (anti-NPM1 was used; 
1:500 dilution; Santa Cruz Biotechnology, California, 
USA) and secondary antibody (goat anti-mouse anti-
body, 1:1 000 dilution, Zhongshan goldenbrioge Bio-
technology Co., Ltd., Beijing, China) for 1 h at 37 °C. 
After  triplicate  washed  with  Tris-Buffered  Saline 
Tween-20 (TBST), the autoradiograms obtained were 
scanned  and  exported  for  densitometry  analysis. 
β-actin  (anti-β-actin  was  used,  1:500  dilution;  Santa 
Cruz  Biotechnology,  California,  USA)  was  used  to 
control the uniform protein content in samples. Three 
independent experiments were performed on the cells 
in independent cultures at 3 different times. 
2.6 Cells proliferation assay  
To measure cells proliferation rate, each group of 
cells  were  seeded  in  96-well  plates  at  a  density  of 
3×103 cells per well. Cells proliferation was quantified 
at 0 h, 24 h, 48 h and 72 h with an MTT assay. 20 μl of 
MTT (5 mg/ml, Sigma, MO, USA) was added to each 
well and cultured for 4 h at 37 °C and 5% CO2. The 
liquid medium in the wells was replaced with 150 μl 
dimethylsulphoxide (DMSO, Sigma, MO, USA), and 
then  the  conversion  of  MTT  into  DMSO-soluble 
formazan by living cells was quantified by measuring 
the absorbance at 490 nm using a spectrophotometer. 
Cells growth curves were plotted with OD value as 
ordinate and time as abscissa. Three independent ex-
periments were performed on the cells in independent 
cultures at 3 different times. 
2.7 Colony formation assay 
Colony formation assay was performed in sem-
isolid culture medium containing 0.9% methylcellu-
lose (Sigma, MO, USA) and 30% FBS. Each group of 
cells  was  seeded  in  dish  at  a  density  of 
1×103/ml/dish.  After  incubating  at  37  °C  with  5% 
CO2 for two weeks, routine colony counts were per-
formed under an inverted microscope (XDS-1B, Bei-
jing,  China).  Aggregates  of  50  or  more  cells  were 
scored  as  one  colony  and  that  of  3~50  cells  as  one 
cluster.  Three  independent  experiments  were  per-
formed on the cells in independent cultures at 3 dif-
ferent times. 
2.8 Flow cytometry assay 
Each  group  of  cells  were  washed  by  PBS  for 
three  times,  and  then  fixed  with  70%  cold  ethanol. 
Cell-cycle analysis was carried out by flow cytometry 
(Becton Dickinson, CA, USA) after propidium iodide 
staining.  Three  independent  experiments  were  per-
formed on the cells in independent cultures at 3 dif-
ferent times. 
2.9 Spectrophotometry detection 
For  determination  of  caspase-3  activity  in  the 
cells, Caspase-3 Assay kit (Clontech, Texas, USA) was 
used according to the manufacturer’s instructions. In 
brief, cells (4 ×106) in each group were routinely har-
vested, mixed with 50 μl cellular lysis buffer and then 
incubated on ice for 30 min. After centrifugation at 4 
°C for 1 min, the supernatant (50 μl) was collected and 
mixed with 50 μl 2× reaction buffer and 5 μl caspase-3 
substrate. The complexes was incubation at 37 °C in 
the  dark  for  4  h,  the  optical  density  values  of  the 
samples  were  read  on  a  spectrophotometer  at  a 
wavelength of 400 nm, which represented the intra-
cellular activity of caspase-3. The activity of caspase-8 
was measured with the same proposal.  Three inde-
pendent experiments were performed on the cells in 
independent cultures at 3 different times. 
2.10 Statistical analysis 
SPSS13.0 software was used for statistical analy-
sis. Results were presented as the mean ± SD for three 
different determinations. A Student’s t-test was used 
to  compare  averaged  values  and  values  of  p<0.05 
were considered statistically significant. 
3. Results 
3.1 Down-regulation of NPM1 in K562 cells with 
RNAi 
To silence NPM1 gene by RNA interference, we 
transfected pNPM1-shRNA with enhanced GFP into 
K562 cells. The results revealed that the percentage of Int. J. Med. Sci. 2011, 8 
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GFP-positive  cells  in  each  group  was  71.5%,  71.2% 
and 72.7%, respectively (Figure 1A), which indicated 
that  the  transfection  efficiency  was  high.  qRT-PCR 
and Western blot analysis showed that both the NPM1 
mRNA and protein levels were significantly lower in 
K562/pNPM1-shRNA  cells  than  those  in  controls 
(p<0.05,  Figure  1B,  C).  No  significant  difference  of 
NPM1 mRNA and protein levels was found among 
the control groups (p>0.05, Figure 1B, C). 
 
 
Figure 1. Transfection of the interference vectors and effect of NPM1 gene silencing on NPM1 expression. A, The ex-
pression of GFP protein in transfected cells was detected by fluorescence microscopy (×200). (a), K562-mock cells; (b), 
K562/pshRNA-NC cells; (c), K562/pNPM1-shRNA cells. A representative example of this transfection results is shown. B, 
The level of NPM1 mRNA expression was detected by qRT-PCR. The expression of NPM1 mRNA in K562/pNPM1-shRNA 
cells was significantly decreased compared with the control groups. Data are shown as means ± SD of triplicate experiments. 
*p <0.05. C, The level of NPM1 protein expression was assessed by Western blot. The average signal intensity was 
standardized to β-actin. The expression of NPM1 protein in K562/pNPM1-shRNA cells was significantly decreased com-
pared with the controls. Data were shown as means ± SD of triplicate experiments. *p <0.05. 
 
 
3.2 Down-regulation of NPM1 suppressed K562 
cells growth  
To  determine  whether  down-regulation  of 
NPM1 has an influence on cells growth in vitro, the 
proliferation of K562 cells was evaluated by an MTT 
assay.  The  result  showed  that,  compared  with  the 
controls,  the  proliferation  of  K562/pNPM1-shRNA 
cells was significantly inhibited in a time-dependent 
manner  and  the  highest  inhibitory  rate  was  (52.7 ± 
2.5%) at 72 h (p < 0.05, Figure 2A). The inhibitory ef-
fect of pNPM1-shRNA on K562 cells growth was also 
confirmed  by  colony  formation  assay.  As  shown  in 
Figure 2B, down-regulation of NPM1 led to 40% re-
duction of colony numbers in K562/pNPM1-shRNA 
cells compared with the controls (p<0.05). These data 
indicated  that  NPM1  silencing  could  significantly 
inhibit K562 cells proliferation. 
3.3 Down-regulation of NPM1 arrested K562 cells 
in the G1 phase 
To evaluate the effect of NPM1 gene silencing on 
the cell cycle progression of K562 cells, the flow cy-
tometry analysis was performed at 48 h after trans-
fection. Results showed that in K562/pNPM1-shRNA 
group, the percentage of cells in G1 phase was signif-
icantly increased, while that in S phase was remarka-
bly decreased (p<0.05, Figure 3 and Table 1). There 
was no significant difference in cell cycle distribution 
among the control groups (p>0.05, Figure 3 and Table 
1). These data indicated that reduction of NPM1 ar-
rested the cell cycle progression. 
0
0.1
0.2
0.3
0.4
0.5
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
 
o
f
 
N
P
M
1
 
p
r
o
t
e
i
n
K562 K562-mock K562/psh
RNA-NC
K562/pNPM1
-shRNA
NPM1
β-actin
0
0.2
0.4
0.6
0.8
1
1.2
﹡
R
e
l
a
t
i
v
e
 
N
P
M
1
m
R
N
A
 
l
e
v
e
l
K562 K562-mock K562/psh
RNA-NC
K562/pNPM1
-shRNA
B C
(a)  (b) (c)
A
﹡Int. J. Med. Sci. 2011, 8 
 
http://www.medsci.org 
291 
 
 
 
Figure 2. Effects of NPM1 gene silencing on the proliferation of K562 cells. A, Cells proliferation was determined by MTT 
assay. At 0 h, 24 h, 48 h, and 72 h, the value of OD in the four groups was measured by absorbance at 490 nm. Treatment of 
K562 cells with pNPM1-shRNA resulted in growth inhibition in a time-dependent manner. Data were shown as means ± SD 
of triplicate experiments. *p<0.05. B, Proliferation potential of cells was determined by colony formation assay. The number 
of colonies in K562/pNPM1-shRNA cells was significantly reduced compared with the controls. Data were shown as mean 
± SD of triplicate experiments, *p<0.05. 
 
Figure 3. Effects of NPM1 gene silencing on cell cycle of K562 cells. The distribution of cell cycle in each group was analysis 
by Flow cytometry. A, K562 cells; B, K562-mock cells;  C, K562/pshRNA-NC cells; D, K562/pNPM1-shRNA cells. A 
representative example of the experimental results is shown. 
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Table 1. Cell cycle distribution of transfected K562 cells 
Transfection group  G1 (%)  S (%)  G2 (%) 
K562  44.75±3.97  52.86±4.63  2.40±1.14 
K562-mock  44.19±2.27  51.30±2.63  4.48±0.90 
K562/pshRNA-NC  47.21±2.72  48.58±2.84  4.23±1.20 
K562/pNPM1-shRNA  57.51±1.67*   36.87±2.88*   5.62±2.14 
Data representd mean ± SD of triplicate experiments, * p<0.05, as compared with K562, K562-mock and K562/pshRNA-NC. 
 
 
 
 
 
Figure 4. Effect of NPM1 gene silencing on the apoptosis of K562 cells. Caspases activities in the cells were measured by 
spectrophotometry. The relative activities of caspases in K562 cells were set as 1, and the values of other groups were 
standardized against it. Both caspase-3 and caspase-8 activities were significantly increased in K562/pNPM1-shRNA cells. 
Data were shown as mean ± SD of triplicate experiments, *p<0.05. A, Relative activity of caspase-3; B, Relative activity of 
caspase-8. 
 
 
3.4 Down-regulation of NPM1 increased K562 
cells apoptosis 
To investigate the effect of NPM1 gene silencing 
on the apoptosis of K562 cells, the activities of caspa-
se-3 and caspase-8 were detected. The results showed 
that, compared with the controls, the relative activity 
of caspase-3 increased by (2.01±0.04) fold in the cells 
of K562/pNPM1-shRNA group (p<0.05,  Figure 4A), 
and  the  relative  activity  of  caspase-8  increased  by 
(1.60±0.07) fold (p<0.05, Figure 4B). However, no sig-
nificantly  change  of  caspase-3  or  caspase-8  activity 
was observed in the controls (p>0.05, Figure 4A, B). 
These findings suggested that NPM1 silencing could 
increase the relative activities of caspases. 
4. Discussions 
NPM1,  a  multifunctional  nucleolar  protein,  is 
found to be more abundant in tumor and aberrant of 
NPM1 has been proved to involve in the pathogenesis 
of diverse human malignancies. NPM1 may function 
as  an  oncogene  by  promoting  aberrant  cell  growth 
and by inhibiting programmed cell death [23]. How-
ever, few of studies reported the oncogenic potential 
of the overexpression NPM1 in hematopoietic malig-
nancies. Here, we identify that reduction of NPM1 by 
RNA interference can inhibit leukemic cells prolifera-
tion and induce cellular apoptosis. 
In  our  study,  RNA  interference,  a  popular  re-
verse  genetic  tool  which  inhibits  gene  expression 
through  sequence-specific  degradation  of  target 
mRNA was  used. In order to avoid non-specific  or 
off-target effects, three pairs of hairpin oligonucleo-
tide  sequences  for  NPM1  had  been  designed  and 
synthesized,  and  the  interference  efficiency  of  each 
one had been detected in the pre-test (data were not 
shown). At last, the most effective one was selected 
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for the further research. In this present study, the in-
terference vector pNPM1-shRNA efficiently reduced 
NPM1 expression at both mRNA and protein levels. 
Since  a  nonspecific  shRNA  was  also  transfected  as 
negative control, reduction of NPM1 was due to spe-
cific  silent  effect  of  pNPM1-shRNA.  Our  results 
showed a similar inhibit efficiency with Li et al [22], 
who silenced the NPM1 with the same target region in 
FA-associated leukemic cell line UoC-M1. 
After  confirming  reduction  of  NPM1  in  the 
K562/pNPM1-shRNA cells, the biological character-
istics in vitro  of  leukemic  cells  were  explored.  MTT 
assays  showed  that  the  cells  growth  of 
K562/pNPM1-shRNA was significantly inhibited in a 
time-dependent manner. Meanwhile, the number of 
colonies  in  the  K562/pNPM1-shRNA  cells  was  sig-
nificantly reduced compared with the controls. These 
findings indicated that reduction of NPM1 accounted 
for  the  inhibition  of  leukemia  cells  proliferation. 
NPM1 is reported to support cell growth based on its 
participation in synthesizing of ribosome and process 
the  pre-rRNA  molecule  in  the  Internal  transcribed 
spacer (ITS2) sequence [24], while knock-down of the 
NPM1 gene in murine cells leads to an alteration in 
their  ribosome  profile  [5].  It  indicates  that 
down-regulation of NPM1 may impair its function on 
ribosome’s synthesis, which may lead to cells growth 
block. In addition, we found the reduction of NPM1 
significantly increased the K562/pNPM1-shRNA cells 
in  G1  phase.  Some  studies  reported  that 
down-regulation  of  NPM1  mRNA  by  an  antisense 
construct resulted in the delay of cells entering mitosis 
[25]. NPM1 expresses highly during S and G2 phases 
and is duplicates concomitantly with the initiation of 
DNA  synthesis  [23],  which  suggested  that 
down-regulation  of  NPM1  may  loss  its  duplicate 
function then delay the entry of cells into mitosis. As a 
result, down-regulation of NPM1 may block the cell 
cycle progression.  
Besides cells proliferation potential, we detected 
the effect of NPM1 gene silencing on the apoptosis of 
the  K562  cells.  Caspase-3  plays  a  crucial  role  in 
apoptotic pathways and its expression is proportional 
to the cells apoptosis. Our results demonstrated that 
the  relative  activity  of  caspase-3  in 
K562/pNPM1-shRNA  cells  was  significantly  in-
creased when compared with the controls, which in-
dicated that reduction of NPM1 could induce apopto-
sis occurrence. In addition, we also detected the ac-
tivity  of  caspase-8.  Caspase-8  is  often  the  apical 
caspase activated in the death receptor systems which 
serves  to  eliminate  unwanted  hematopoietic  cells 
through apoptosis. Some studies have indicated that 
interferon  regulatory  factor  1  (IRF-1)  could  activate 
caspase-8  to  induce  apoptosis  [26].  It  also  has  been 
reported that overexpression of NPM1 suffered from 
IRF-1 inactivation and resist cell apoptosis [23]. In our 
study,  the  relative  activity  of  caspase-8  in 
K562/pNPM1-shRNA  cells  was  significantly  in-
creased,  which  indicated  that  induction  of  cellular 
apoptosis by silencing of NPM1 gene was associated 
with the change of caspase-8 activity. However, it is 
important  to  further  study  the  exact  molecular 
mechanisms of NPM1 on the apoptosis of leukemia 
cells.  
In conclusion, our results demonstrated that in-
hibition  of  NPM1  decreased  leukemia  cells  growth 
and induced cellular apoptosis. This new information 
casts a light on the oncogenic potential of the NPM1 
overexpression in leukemia. However, to clarify the 
role of NPM1 in regulation of  hematological malig-
nancies, the effect of NPM1 overexpression on the cell 
biological  behaviors  still  be  investigated  in  the  pri-
mary samples.  
Acknowledgements 
This project was supported by a grant from Na-
tional  Natural  Science  Foundation  of  China  (No. 
30872418) and Natural Science Foundation Project of 
CQ CSTC (No. 2010BB5363). 
Conflict of Interests 
The authors have declared that no conflict of in-
terest exists. 
References 
1.  Chan  WY,  Liu  QR,  Borjigin  J,  et  al.  Characterization  of  the 
cDNA encoding human nucleophosmin and studies of its role 
in normal and abnormal growth. Biochemistry. 1989; 28: 1033-9.  
2.  Okuwaki,  M.  The  structure  and  functions  of 
NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic 
protein. J Biochem. 2008; 143: 441-8. 
3.  Sirri V, Roussel P, Gendron MC, et al. Amount of the two major 
Ag-NOR proteins, nucleolin and protein B23, is cell-cycle de-
pendent. Cytometry. 1997; 28: 147-56. 
4.  Wu  MH,  Yung  BY.  UV  stimulation  of  nucleophosmin/B23 
expression  is  an  immediate-early  gene  response  induced  by 
damaged DNA. J Biol Chem. 2002; 277: 48234-40. 
5.  Grisendi S, Bernardi R, Rossi M, et al. Role of nucleophosmin in 
embryonic development and tumorigenesis. Nature. 2005; 437: 
147-53. 
6.  Colombo E, Bonetti P, Lazzerini Denchi E, et al. Nucleophosmin 
is required for DNA integrity and p19Arf protein stability. Mol 
Cell Biol. 2005; 25: 8874-86. 
7.  Shields  LB,  Gerçel-Taylor  C,  Yashar  CM,  et  al.  Induction  of 
immune responses to ovarian tumor antigens by multiparity. J 
Soc Gynecol Investig. 1997; 4: 298-304. 
8.  Nozawa Y, Van Belzen N, Van der Made AC, et al. Expression 
of  nucleophosmin/B23  in  normal  and  neoplastic  colorectal 
mucosa. J Pathol. 1996; 178: 48-52. 
9.  Tanaka  M,  Sasaki  H,  Kino  I,  et  al.  Genes  preferentially  ex-
pressed  in  embryo  stomach  are  predominantly  expressed  in 
gastric cancer. Cancer Res. 1992; 52: 3372-7.  Int. J. Med. Sci. 2011, 8 
 
http://www.medsci.org 
294 
10.  Subong EN, Shue MJ, Epstein JI, et al.  Monoclonal antibody to 
prostate cancer nuclear matrix protein (PRO:4–216) recognizes 
nucleophosmin/B23. Prostate. 1999; 39: 298-304. 
11.  Pianta A, Puppin C, Franzoni A et al. Nucleophosmin is over-
expressed in thyroid tumors. Biochem Biophys Res Commun. 
2010; 397: 499-504. 
12.  Feuerstein N, Chan PK, Mond JJ. The nuclear matrix protein, 
numatrin (B23), is associated with growth factor-induced mi-
togenesis in Swiss 3T3 fibroblasts and with T lymphocyte pro-
liferation stimulated by lectins and anti-T cell antigen receptor 
antibody. J Cell Biol. 1988; 107: 1629-42. 
13.  Kondo T, Minamino N, Nagamura-Inoue T, et al. Identification 
and  characterization of  nucleophosmin/B23/numatrin  which 
binds the anti-oncogenic transcription factor IRF-1 and mani-
fests oncogenic activity. Oncogene. 1997; 15: 1275-81. 
14.  Morris  SW,  Xue  L,  Ma  Z,  et  al.  Alk+  CD30+  lymphomas:  a 
distinct molecular genetic subtype of non-Hodgkin’s lympho-
ma. Br J Haematol. 2001; 113: 275-95. 
15.  Pandolfi  PP.  PML,  PLZF  and  NPM  genes  in  the  molecular 
pathogenesis of acute promyelocytic leukemia. Haematologica. 
1996; 81: 472-82. 
16.  Yoneda-Kato N, Look AT, Kirstein MN, et al. The t (3; 5) (q25.1; 
q34) of myelodysplastic syndrome and acute myeloid leukemia 
produces a novel fusion gene, NPM–MLF1. Oncogene. 1996; 12: 
265–75. 
17.  Hsu  CY,  Yung  BY.  Over-expression  of  nucleophosmin/B23 
decreases the susceptibility of human leukemia HL-60 cells to 
retinoic acid-induced differentiation and apoptosis. Int J Can-
cer. 2000; 88: 392-400. 
18.  Hsu  CY,  Yung  BY.  Involvement  of  nucleophosmin/B23  in 
TPA-induced megakaryocytic differentiation of K562 cells. Br J 
Cancer. 2003; 89: 1320-26. 
19.  Liu WH, Hsu CY, Yung BY. Nucleophosmin/B23 regulates the 
susceptibility of human leukemia HL-60 cells to sodium butyr-
ate-induced apoptosis and inhibition of telomerase activity. Int 
J Cancer. 1999; 83: 765-71. 
20.  Liu,  WH,  Yung  BY.  Mortalization  of  human  promyelocytic 
leukemia HL-60 cells to be more susceptible to sodium butyr-
ate-induced apoptosis and inhibition of telomerase activity by 
down-regulation of nucleophosmin/B23. Oncogene. 1998;  17: 
3055-64. 
21.  Bolli N, De Marco MF, Martelli MP, et al. A dose-dependent tug 
of war involving the NPM1 leukaemic mutant, nucleophosmin, 
and ARF. Leukemia. 2009; 23: 501-9. 
22.  Li J, Zhang X, Sejas DP, et al. Negative regulation of p53 by 
nucleophosmin antagonizes stress-induced apoptosis in human 
normal and malignant hematopoietic cells. Leuk Res. 2005; 29: 
1415-23. 
23.  S.  Grisendi, C.  Mecucci,  B.  Falini,  et  al.  Nucleophosmin and 
cancer. Nat Rev Cancer. 2006; 6: 493-505. 
24.  Herrera JE, Savkur R, Olson MO. The ribonuclease activity of 
nucleolar protein B23. Nucleic Acids Res. 1995; 23: 3974-79. 
25.  Jiang  PS,  Yung  BY.  Down-regulation  of  nucleophosmin/B23 
mRNA delays the entry of cells into mitosis. Biochem Biophys 
Res Commun. 1999; 257: 865-70. 
26.  Bouker KB, Skaar TC, Riggins RB, et al. Interferon regulatory 
factor-1 (IRF-1) exhibits tumor suppressor activities in breast 
cancer  associated  with  caspase  activation  and  induction  of 
apoptosis. Carcinogenesis. 2005; 26: 1527-35. 